Background: Traditional fermented cheese whey (TFCW), containing probiotics, has been used both as a dairy food with ethnic flavor and a medicine for cardiovascular disease, especially regulating blood lipid among Kazakh. We therefore investigated anti-atherosclerotic effects of TFCW in atherosclerotic rabbits and identified lactic acid bacteria (LAB) and yeasts in TFCW.
Background
The public health burden of cardiovascular disease (CVD) is substantial, as CVD remains the leading cause of mortality and morbidity worldwide and atherosclerosis is the major cause of CVD [1, 2] .
Traditional fermented cheese whey (TFCW), by-product of cheese-making, has been widely used as a traditional dairy medication for regulating blood lipid among Kazakh people [3] . Indeed, active peptides in TFCW up-regulate expression of peroxisome proliferator-activated receptor-γ (PPAR-γ) mRNA [3] , which reduces atherosclerosis [4] . Furthermore, whey protein and peptides have a protective effect against CVD risk factors [5] .
Probiotics mainly include Lactobacillus and Bifidobacterium and a few yeast species including Saccharomyces boulardi [6] . Lactic acid bacteria (LAB) are the main probiotics that prevent formation of aortic fatty lesions by inhibiting low-density lipoprotein (LDL) oxidation [7] and atherosclerosis via the inhibition of intestinal cholesterol absorption [8] in animal models. S. boulardii, one of the probiotic yeasts, provides anti-inflammatory and host immunity stimulatory effects [9] and lowers remnant lipoprotein, a highly atherogenic lipoprotein particle, in human adults with hypercholesterolemia [10] .
However, anti-atherosclerotic effects of TFCW have not been experimentally demonstrated and no LAB or yeast has been found in TFCW. The aims of this study were to investigate anti-atherosclerotic effects of TFCW in a rabbit model of atherosclerosis and to identify LBA and yeast in TFCW.
Methods

Traditional fermented cheese whey (TFCW) manufacturing
Traditional fermented cow's milk is the source of the cheese whey. Experimental TFCW samples were manufactured by standard procedures in 10 L vats in Altay Kanas Dairy Co. Ltd., (Altay, Xinjiang, China). Fresh cow's milk samples were obtained from Jimunai Saur farm (Altay, Xinjiang, China) and skimmed in centrifuging at 3000 × g for 30 min, homogenized under the pressure of 1.5~1.7 Mpa and pasteurized by high temperature short time (HTST) then cooled to about 30°C and fermented by inoculation with traditional home made Kazak yogurt purchased from Jimunai Saur farm (Altay, Xinjiang, China) at 37°C for 12 h. After ferment, the whey was filtered in sterile gauze and dialyzed in cellulose membrane (12 kDa, Sigma) under constant magnetic stirring at 8°C, also performed lactose removal by periodic water exchange. The experimental TFCW was stored at −20°C until further use.
Chemicals and reagents
Sodium pentobarbital was purchased from Merck & Co., (Germany). Simvastatin was purchased from Merck Sharp & Dohme (Australia) Pty Ltd., (Hangzhou, China). VCAM-1, ICAM-1 and CRP ELISA kits were purchased from Shanghai Senxiong Technology Co. Ltd., (Shanghai, China). Man Rogosa Sharpe (MRS) was purchased from Merck Sharp & Dohme (Australia) Pty Ltd., (Hangzhou, China). All media for cultivation of zymocytes were purchased from Hangzhou Microbial Reagent Co. Ltd., (Hangzhou, China).
Animals and treatment
Sixty male white New Zealand rabbits, weighing 1.95-2.05 kg, specific pathogen free (SPF), were provided by Experimental Animal Center of Xinjiang Medical University, China and placed in separate cages and maintained on a 12-h day/night cycle at an ambient temperature, with ad libitum access to food and water. After a week of adaptive feeding, all the rabbits were randomly divided into 5 groups with 12 in normal group and 12 in atherogenic group, the normal control groups were given regular die and the atherogenic models were developed using an atherogenic diet for 12 weeks. The atherogenic diet consisted of 3 % cholesterol, 0.5 % sodium taurocholate, 0.2 % propylthiouracil, 5 % sugar, 10 % lard, and 81.3 % standard laboratory rabbit chow, which were provided by Experimental Animal Center of Xinjiang Medical University, China. After developing atherogenic models, Group 1 (normal control) was treated with saline in a matched volume; Group 2 (atherogenic group) had atherogenic rabbits treated with saline in a matched volume; Group 3 (positive control) had atherogenic rabbits administered with simvastatin 20 mg/kg; Group 4 and Group 5 were treated with TFCW 25 mg/kg and 50 mg/kg, respectively (low and high doses). Simvastatin and TFCW were intragastrical administered once daily 10 mL/kg for 4 weeks. All animals received care in compliance with the Chinese Convention on Animal Care, and the study was approved by the Institutional Ethics Committee of Xinjiang Medical University.
Collection of blood and biochemical measurement
At the end of experiments, all rabbits were fasted for 12 h, weighed, anesthetized with sodium pentobarbital (Merck & Co.,) and continually monitored until total loss of consciousness as indicated by a total lack of response after a foot pinch. Blood samples were collected from abdominal aorta, allowed to clot on ice and subsequently subjected to centrifugation (3500 rpm at 4°C for 10 min), where after serum aliquots were stored at −80°C for further analysis. Serum TC, TG, LDL-C and HDL-C were examined via an automatic biochemical analyzer (BS-120, Shenzhen Mindray High-Tech Co., Ltd. China). CRP was determined by rate nephelometry (Beckman Coulter, USA). Serum ICAM-1 and VCAM-1 were determined using commercially-available ELISA kits according to manufacturer instruction.
Histopathological study of aorta
Aorta was harvested from rabbits, placed immediately in formaldehyde 10 %, embedded in paraffin 24 h later, cut at 5 μm, stained with hematoxylin and eosin (H&E), and then scanned to assess pathological changes. For immunohistochemical staining, sections were incubated with anti-VCAM-1 (R&D Systems, MN, USA) and anti-F4/80 (Abcam, MA, USA) at 37°C for 1 h, color developed with 3,3′-diaminobenzidine tetrahydrochloride and counterstained with hematoxylin. Samples in the absence of the primary antibodies were used as negative controls. Slides were observed under a light microscope, and images were subjected to statistical evaluation of positively stained cells in 10 random fields of view at a magnification of × 400. The average numbers of positively stained cells were counted per high power field (HPF).
Isolation, purification and characterization of LAB
Agar plates with Man Rogosa Sharpe (MRS) broth suitable for lactobacillus growth were used for initial isolation of LAB single colonies. Single bacterial colonies were initially separated based on their morphological differences on agar plates. Cell morphology was observed under light microscopy after Gram staining. Catalase activity, carbohydrate fermentation, acidogenicity, aciduricity (final pH), and gas (CO 2 ) production were analyzed. All isolates were presumptively identified as LAB strains based on their ability to grow on MRS agar plates, Gram-positive staining, and a catalase activity-negative phenotype [11] . 16S rDNA and 16S rRNA of 7 isolates were initially analyzed by BLAST program on NCBI website to search for the best matches among existing data in GenBank. 16S rDNA and 16S rRNA gene sequence analyses were carried out at Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Isolation, purification and identification of yeasts
Each 100 μl sample was enriched in a tube containing Sabourauds agar medium, incubated at 25°C for 48-72 h and spread on Sabourauds agar. Representative yeast colonies were selected based on colonial characteristics, purified using a single colony isolation method, and maintained on a Sabourauds agar slant at 4°C or in freezing tubes containing Sabourauds agar broth supplemented with 10 % glycerol at −80°C. Physiological and biochemical characteristic identifications were made according to results of carbohydrate fermentation, carbon source assimilation, nitrogen assimilation and temperature tests. All these tests and analyses of 26S rDNA D1/D2 gene sequences were performed using identical methods as those used for bacteria.
Statistical analysis
All values were reported as mean ± S.E.M. Data were analyzed by one-way ANOVA using SPSS 18 (SPSS Inc., Chicago, Illinois, USA). Significance was defined as * P < 0.05 compared to atherogenic group. Table 1 showed serum lipid profiles among different experimental groups. Serum TC, TG, HDL-C and LDL-C of rabbits were significantly higher in atherogenic group than in normal control group (p < 0.05), whereas Simvastatin group and low and high dose TFCW group showed significantly lower serum TC, TG and LDL-C than did atherogenic group (p < 0.05). TFCW significantly increased HDL-C levels compared to normal control group (p < 0.05), but no significant difference was observed in treated groups with TFCW, compared with atherogenic group. Data indicated that TFCW affects lipid metabolic parameters and TFCW treatment could effectively improve lipid metabolism in atherogenic rabbits.
Results
Effects of TFCW on Lipid Profiles
Effects of TFCW on CRP levels and body weight
Serum CRP was measured to determine inflammatory status of experimental groups as shown in Table 2 . Generally, atherogenic group had significantly higher CRP, compared with the normal control group (15.03 ± 9.12 vs 0.98 ± 0.03 mg/L, P < 0.05). Outstandingly, the simvastatin and low and high dose TFCW groups had significantly lower CRP (P < 0.05) at values 3.43 ± 0.80 mg/L, 3.33 ± 0.50 mg/L and 1.34 ± 0.90 mg/L, respectively, compared with the atherogenic group. CRP in low and 
Effects of TFCW on ICAM-1 and VCAM-1
Adhesion molecules ICAM-1 and VCAM-1 play important roles in perpetuation of inflammation. Table 2 showed serum ICAM-1 and VCAM-1 among different experimental groups. ICAM-1 and VCAM-1 of rabbits were significantly higher in atherogenic group than in normal control group (p < 0.05), while Simvastatin and low and high dose TFCW group showed significantly decreased ICAM-1 and VCAM-1, compared to atherogenic group (p < 0.05). Data indicated that TFCW might affect ICAM-1 and VCAM-1 and TFCW treatment might effectively inhibit adhesion of circulating inflammatory cells to endothelial cell walls in atherogenic rabbits.
Effects of TFCW on histopathological changes in the aorta
Histopathological examination of aorta sections from experimental groups were shown in Fig. 1 
Effects of TFCW on immunohistochemistry assessment in the aorta
Immunohistochemical evaluation of VCAM-1 expression in aorta section and histomorphometric analysis from experimental groups were shown in Fig. 2 . Atherogenic group showed strong VCAM-1 staining, compared to normal control group. Simvastatin and low and high dose TFCW groups showed less VCAM-1 expression than did atherogenic group, which indicated that TFCW may have a preventive effect in atherogenic rabbits.
Identification of LAB
Seven gram-positive, catalase-negative bacilli were isolated from TFCW. Most of the bacilli had yellow or white colonies with uneven edges and a rough and dull surface. Some of the colonies in the center were translucent, with neat edges. The type colony size was approximately 0. Table 3 , while all of the sequences were as follows: CCAGAGTGCCCAACTGAATGCTGGCAACTG  ATAATAAGGGTTGCGCTCGTTGCGGGACTTA  ACCCAACATCTCACGACACGAGCTGACGAC  AACCATGCACCACCTGTCATTCTGTCCCCGA  AGGGAACGTCTTATCTCTAAGATTGGCAGAA  GATGTCAAGACCTGGTAAGGTTCTTCGCGTA  GCTTCGAATTAAACCACATGCTCCACCGCTT  GTGCGGGCCCCCGTCAATTCCTTTGAGTTTC  AACCTTGCGGTCGTACTCCCCAGGCGGAGTG  CTTAATGCGTTAGCTGCAGCACTGAAGGGCG  GAAACCCTCCAACACTTAGCACTCATCGTTT  ACGGCATGGACTACCAGGGTATCTAATCCTG  TTCGCTACCCATGCTTTCGAGCCTCAGCGTC  AGTTACAGACTAGACAGCCGCCTTCGCCACT  GGTGTTCTTCCATATATCTACGCATTCCACCG  CTACACATGGAGTTCCACTGTCCTCTTCTGC  ACTCAAGTCTCCCAGTTTCCGATGCACTTCT  CCGGTTAAGCCGAAGGCTTTCACATCAGACT  TAAAAAACCGCCTGCGCTCGCTTTACGCCCA  ATAAATCCGGACAACGCTTGCCACCTACGTAT  TACCGCGGCTGCTGGCACGTAGTTAGCCGTG   GCTTTCTGGTTAAATACCGTCAACCCTTGAA  CAGTTACTCTCAAAGGTGTTCTTCTTTAACAA  CAGAGTTTTACGAGCCGAAACCCTTCTTCAC  TCACGCGGCATTGCTCCATCAGACTTTCGTC  CATTGTGGAAGATTCCCTACTGCTGCCTCCC  GTAGGAGTTTGGGCCGTGTCTCAGTCCCAAT  GTGGCCGATTACCCTCTCAGGTCGGCTACGT  ATCATCGTCTTGGTGGGCCTTTACCTCACCA  ACTAACTAATACGCCGCGGGATCATCCAGAA  GTGATAGCCGAANCCACCTTTCAAACAAAAT  CCATGCGGATTTTGTTGTTATACGGTATTAGC  ACCTGTTTCCAAGTGTTATCCCCTGCTTCTG  GGCAGATTTCCCACGTGTTACTCACCAGTTC  GCCACTCGCTTCATTGTTGAAATCAANGCAA  GCACGTCATTCAACGGAAGCTCGTTCGACT TTTCAGAGAATTGCTTGCCTTTGCAGGCTCG  CTGCTCGTTGTGCTGCCCATTGTAGCACGTG  TGTAGCCCAGGTCATAAGGGGCATGATGACT  TGACGTCATCCCCACCTTCCTCCGGTTTGTC  ACCGGCAGTCTCATTAGAGTGCCCAACTTAA  TGCTGGCAACTAATAACAAGGGTTGCGCTCG  TTGCGGGACTTAACCCAACATCTCACGACA  CGAGCTGACGACAGCCATGCACCACCTGTCT  TAGCGTCCCCGAAGGGAACTTTGTATCTCTA  CAAATGGCACTAGATGTCAAGACCTGGTAA  GGTTCTTCGCGTTGCTTCGAATTAAACCACA  TGCTCCACCGCTTGTGCGGGCCCCCGTCAAT  TCCTTTGAGTTTCAACCTTGCGGTCGTACTC  CCCAGGCGGAGTGCTTAATGCGTTAGCTGCA  GCACTGAGAGGCGGAAGCCTCCCAACACTT  AGCACTCATCGTTTACGGCATGGACTACCAG  GGTATCTAATCCTGTTCGCTACCCATGCTTTC  GAGCCTCAGCGTCAGTTGCAGACCAGAGAG  CCGCCTTCGCCACTGGTATTCTTCCATATAT  CTACGCATTCCACCGCTACACATGGAGTTCTA   CTCTCCTCTTCTGCACTCAAGAAAAACAGTT  TCCGATGCAATTCCTCGGTTAAGCCGAGGGC  TTTCACATCAGACTTATTCTTCCGCCTGCGCT  CGCTTTACGCCCAATAAATCCGGACAACGCT  TGCCACCTACGTATTACCGCGGCTGCTGGCA  CGTAGTTAGCCGTGACTTTCTGGTTGATTAC  CGTCAAATAAAGGCCAGTTACTACCTCTATCC  TTCTTCACCAACAACAGAGCTTTACGGTCCG  AAAACCTTCTTCACTCACGCGGCGTTGCTCC  ATCAGACTTGCGTCCATTGTGGAAGATTCCC  TACTGCTGCCTCCCGTANGAGTTTGGGCCGT  GTCTCAGTCCCAATGTGGCCGATCAGTCTCT  CAACTCGGCTATGCATCACTGCCTTGGTAGG  CCGTTACCTTACCAACTAGCTAATGCACCGC  GGGTCCATCCTTTAGCGACAGCTTGCGCCGC  CTTTTAAAAGCTGTTCATGCGAACTGCTTTC  TTATCCGGTATTAGCACCTGTTTCCAAGTGGT  ATCCCAGACTTAAGGGCAGGTTCCCCACGTG  TTACTCACCCATCCGCCGCTCGCTTTCCCAG TTAGACGGCTCCTTCCCGAAGGTTAGGCCA  CCGGCTTTGGGCATTGCAGACTTCCATG  GTGTGACGGGCGGTGTGTACAAGGCCCGG  GAACGTATTCACCGCGGCGTTCTGATCCGCG  ATTACTAGCGATTCCAGCTTCGTGCAGTCGA  GTTGCAGACTGCAGTCCGAACTGAGAACA  GCTTTCAGAGATTCGCTTGCCTTCGCAGGC  TCGCTTCTCGTTGTACTGTCCATTGTAGCAC   GTGTGTAGCCCAGGTCATAAGGGGCATGAT  GACTTGACGTCATCCCCACCTTCCTCCGGTT  TGTCACCGGCAGTCTCATTAGAGTGCCCAAC  TTAATGCTGGCAACTAATAACAAGGGTTGCG  CTCGTTGCGGGACTTAACCCAACATCTCACG  ACACGAGCTGACGACAGCCATGCACCACCTG  TCTTAGCGTCCCCGAAGGGAACTCCTAATCT  CTTAGGATGGCACTAGATGTCAAGACCTGGT  AAGGTTCTTCGCGTTGCTTCGAATTAAACCA   Table 3 Biochemical characteristics of LAB isolated from TFCW CATGCTCCACCGCTTGTGCGGGCCCCCGTCA  ATTCCTTTGAGTTTCAACCTTGCGGTCGTAC  TCCCCAGGCGGAGTGCTTAATGCGTTAGCTG  CAGCACTGAGAGGCGGAAACCTCCCAACACT  TAGCACTCATCGTTTACGGCATGGACTACCA  GGGTATCTAATCCTGTTCGCTACCCATGCTTT  CGAGCCTCAGCGTCAGTTGCAGACCAGAGA  GTCGCCTTCGCCACTGGTGTTCTTCCATATA  TCTACGCATTCCACCGCTACACATGGAGTTCC  ACTCTCCTCTTCTGCACTCAAGAAAAACAGT  TTCCGATGCAGTTCCTCGGTTAAGCCGAGGG  CTTTCACATCAGACTTATTCTTCCGCCTGCGC  TCGCTTTACGCCCAATAAATCCGGACAACGC  TTGCCACCTACGTATTACCGCGGCTGCTGGC  ACGTAGTTAGCCGTGACTTTCTGGTTGATTA  CCGTCAAATAAAGGCCAGTTACTACCTCTAT  CCTTCTTCACCAACAACAGAGCTTTACGATC  CGAAAACCTTCTTCACTCACGCGGCGTTGCT  CCATCAGACTTGCGTCCATTGTGGAAGATTC  CCTACTGCTGCCTCCCGTAGGAGTTTGGGCC  GTGTCTCAGTCCCAATGTGGCCGTTCAGTCT  CTCAACTCGGCTATGCATCATTGCCTTGGTA  AGCCGTTACCTTACCAACTAGCTAATGCACC  GCGGGGCCATCCCATAGCGACAGCTTACGCC  GCCTTTTATAAGCTGATCATGCGATCTGCTTT  CTTATCCGGTATTAGCACCTGTTTCCAAGTG  GTATCCCAGACTATGGGGCAGGTTCCCCACG  TGTTACTCACCCATCCGCCGCTCGCGTCCCC  AGCATCATTACCGAAGTAAATCTGCTGGTTCT  GCTCGCTCGACTGCATGTAT  4. L. casei:  TAGACGGCTCGCTCCCTAAAAGGGTTACGCC  ACCGGCTTCGGGTGTTACAAACTCTCATGGT  GTGACGGGCGGTGTGTACAAGGCCCGGGAA  CGTATTCACCGCGGCGTGCTGATCCGCGATT  ACTAGCGATTCCGACTTCGTGTAGGCGAGTT  GCAGCCTACAGTCCGAACTGAGAATGGCTTT  AAGAGATTAGCTTGACCTCGCGGTCTCGCAA  CTCGTTGTACCATCCATTGTAGCACGTGTGTA  GCCCAGGTCATAAGGGGCATGATGATTTGAC  GTCATCCCCACCTTCCTCCGGTTTGTCACCG  GCAGTCTTACTAGAGTGCCCAACTAAATGCT  GGCAACTAGTCATAAGGGTTGCGCTCGTTGC  GGGACTTAACCCAACATCTCACGACACGAGC  TGACGACAACCATGCACCACCTGTCATTTTG  CCCCCGAAGGGGAAACCTGATCTCTCAGGTG  ATCAAAAGATGTCAAGACCTGGTAAGGTTCT  TCGCGTTGCTTCGAATTAAACCACATGCTCC  ACCGCTTGTGCGGGCCCCCGTCAATTCCTTT  GAGTTTCAACCTTGCGGTCGTACTCCCCAGG  CGGAATGCTTAATGCGTTAGCTGCGGCACTG  AAGGGCGGAAACCCTCCAACACCTAGCATTC  ATCGTTTACGGCATGGACTACCAGGGTATCT  AATCCTGTTCGCTACCCATGCTTTCGAGCCT   CAGCGTCAGTTACAGACCAGACAGCCGCCTT  CGCCACTGGTGTTCTTCCATATATCTACGCAT  TTCACCGCTACACATGGAGTTCCACTGTCCT  CTTCTGCACTCAAGTTTCCCAGTTTCCGATG  CGCTTCCTCGGTTAAGCCGAGGGCTTTCACA  TCAGACTTAAAAAACCGCCTGCGCTCGCTTT  ACGCCCAATAAATCCGGATAACGCTTGCCAC  CTACGTATTACCGCGGCTGCTGGCACGTAGT  TAGCCGTGGCTTTCTGGTTGGATACCGTCAC  GCCGACAACAGTTACTCTGCCGACCATTCTT  CTCCAACAACAGAGTTTTACGACCCGAAAGC  CTTCTTCACTCACGCGGCGTTGCTCCATCAG  ACTTGCGTCCATTGTGGAAGATTCCCTACTG  CTGCCTCCCGTANNAGTTTGGGCCGTGTCTC  AGTCCCAATGTGGCCGATCAACCTCTCAGTT  CGGCTACGTATCATCGCCTTGGTGAGCCATT  ACCTCACCAACTAGCTAATACGCCGCGGGTC  CATCCAAAAGCGATAGCTTACGCCATCTTTC  AGCCAAGAACCATGCGGTTCTTGGATCTATG  CGGTATTAGCATCTGTTTCCAAATGTTATCCC  CCACTTAAGGGCAGGTTACCCACGTGTTACT  CACCCGTCCGCCACTCGTTCCATGTTGAATC  TCGGTGCAAGCACCGATCATCAACGAGAACT  CGTTCGACTGCATGTATAGC  5. L. plantarum:  GGCGTGCCTAATACATGCAAGTCGAACGAAC  TCTGGTATTGATTGGTGCTTGCATCATGATT  TACATTTGAGTGAGTGGCGAACTGGTGAGT  AACACGTGGGAAACCTGCCCAGAAGCGGGG  GATAACACCTGGAAACAGATGCTAATACCGC  ATAACAACTTGGACCGCATGGTCCGAGTTTG  AAAGATGGCTTCGGCTATCACTTTTGGATGG  TCCCGCGGCGTATTAGCTAGATGGTGGGGTA  ACGGCTCACCATGGCAATGATACGTAGCCGA  CCTGAGAGGGTAATCGGCCACATTGGGACTG  AGACACGGCCCAAACTCCTACGGGAGGCAGC  AGTAGGGAATCTTCCACAATGGACGAAAGTC  TGATGGAGCAACGCCGCGTGAGTGAAGAAG  GGTTTCGGCTCGTAAAACTCTGTTGTTAAAG  AAGAACATATCTGAGAGTAACTGTTCAGGTA  TTGACGGTATTTAACCAGAAAGCCACGGCTA  ACTACGTGCCAGCAGCCGCGGTAATACGTAG  GTGGCAAGCGTTGTCCGGATTTATTGGGCGT  AAAGCGAGCGCAGGCGGTTTTTTAAGTCTGA  TGTGAAAGCCTTCGGCTCAACCGAAGAAGTG  CATCGGAAACTGGGAAACTTGAGTGCAGAAG  AGGACAGTGGAACTCCATGTGTAGCGGTGAA  ATGCGTAGATATATGGAAGAACACCAGTGGC  GAAGGCGGCTGTCTGGTCTGTAACTGACGCT  GAGGCTCGAAAGTATGGGTAGCAAACAGGAT  TAGATACCCTGGTAGTCCATACCGTAAACGAT  GAATGCTAAGTGTTGGAGGGTTTCCGCCCTT  CAGTGCTGCAGCTAACGCATTAAGCATTCCG  CCTGGGGAGTACGGCCGCAAGGCTGAAACTC AAAGGAATTGACGGGGGCCCGCACAAGCGG  TGGAGCATGTGGTTTAATTCGAAGCTACGCG  AAGAACCTTACCAGGTCTTGACATACTATGC  AAATCTAAGAGATTAGACGTTCCCTTCGGGG  ACATGGATACAGGTGGTGCATGGTTGTCGTC  AGCTGGTGTCGTGAGATGTTGGGTTAAGTCC  CGCAACGAGCGCAACCCTTATTATCAGTTGC  CACCATTAAGTTGGGCACTCTGGTGAGACTG  CCGGTGACAAACCGGAGGAAGGTGGGGATG  ACGTCAAATCATCATGCCCCTTATGACCTGGG  CTACACACGTGCTACAATGGATGGTACAAGG  AGTTGCGAACTCGCGAGAGTAAGCTAATCTC  TTAAAGCCATTCTCAGTTCGGATTGTAGGCT  GCAACTCGCCTACATGAAGTCGGAATCGCTA  GTAATCGCGGATCAGCATGCCGCGGTGAATA  CGTTCCCGGGCCTTGTACACACCGCCCGTCA  CACCATGAGAGTTTGTAACACCCAAAGTCGG  TGGGGTAACCTTTTAGGAACCAGCCGCCTAA  GGTGG  6. L. kefiri:  CTTAGACGGCTGGTCCCCGAAGGTTACCTCA  CCGGCTTTGGGTGTTACAAACTCTCATGGTG  TGACGGGCGGTGTGTACAAGGCCCGGGAAC  GTATTCACCGTGGCATGCTGATCCACGATTAC  TAGCGATTCCAACTTCATGCAGGCGAGTTGC  AGCCTGCAATCCGAACTGAGAACGGCTTTAA  GAGATTAGCTTGACCTCGCGGTTTCGCGACT  CGTTGTACCGTCCATTGTAGCACGTGTGTAG  CCCAGGTCATAAGGGGCATGATGATTTGACG  TCATCCCCACCTTCCTCCGGTTTGTCACCGG  CAGTCTTGCTAGAGTGCCCAACTGAATGCTG  GCAACTAACAATAAGGGTTGCGCTCGTTGCG  GGACTTAACCCAACATCTCACGACACGAGCT  GACGACAACCATGCACCACCTGTCATTCTGT  CCCCGAAGGGAACGCCTAATCTCTTAGGTTG  GCAGAAGATGTCAAGACCTGGTAAGGTTCTT  CGCGTAGCATCGAATTAAACCACATGCTCCA  CCGCTTGTGCGGGCCCCCGTCAATTCCTTTG  AGTTTCAACCTTGCGGTCGTACTCCCCAGGC  GGAGTGCTTAATGCGTTAGCTGCAGCACTGA  AGGGCGGAAACCCTCCAACACTTAGCACTCA  TCGTTTACGGCATGGACTACCAGGGTATCTA  ATCCTGTTCGCTACCCATGCTTTCGAGCCTC  AGCGTCAGTTACAGACCAGACAGCCGCCTTC  GCCACTGGTGTTCTTCCATATATCTACGCATT  TCACCGCTACACATGGAGTTCCACTGTCCTC  TTCTGCACTCAAGTCTCCTGGTTTCCGATGC  ACTTCTCCGGTTAAGCCGAAGGCTTTCACAT  CAGACCTAAGAAACCGCCTGCGCTCGCTTTA  CGCCCAATAAATCCGGACAACGCTTGCCACC  TACGTATTACCGCGGCTGCTGGCACGTAGTT  AGCCGTGGCTTTCTGGTTGGATACCGTCAAG  ATGTCAACAGTTACTCTGACACCTGTTCTTCT  CCAACAACAGAGTTTTACGAGCCGAAACCCT   TCATCACTCACGCGGCGTTGCTCCATCAGAC  TTTCGTCCATTGTGGAAGATTCCCTACTGCT  GCCTCCCGTAGGAGTTTGGGCCGTGTCTCAG  TCCCAATGTGGCCGATTACCCTCTCAGGTCG  GCTACGTATCATTGCCTTGGTAGGCCATTACC  TTACCAACAAGCTAATACGCCGCGGGTCCAT  CCTAAAGTGATAGCCGAAGCCATCTTTTAAA  CCAAAACCATGTGGTTTTGGTTGTTATACGG  TATTAGCACCTGTTTCCAAGTGTTATCCCCT  ACTTCAAGGGCAGGTTACCCACGTGTTACTC  ACCAGTTCGCCACTCGTTTCGTGTTAAATCAT  TTAAATGCAAGCATCTAAAATCAATAACGGAA  ACGCGTTCGACTTGCATGTAT  7. Lactococcus lactic:  GGTCTTACCTTAGGAAGCGCCCTCCTTGCGG  TTAGGCAACCTACTTCGGGTACTCCCAACTC  CCGTGGTGTGACGGGCGGTGTGTACAAGGC  CCGGGAACGTATTCACCGCGGCGTGCTGATC  CGCGATTACTAGCGATTCCGACTTCATGTAG  GCGAGTTGCAGCCTACAATCCGAACTGAGAA  TGGTTTTAAGAGATTAGCTAAACATCACTGTC  TCGCGACTCGTTGTACCATCCATTGTAGCAC  GTGTGTAGCCCAGGTCATAAGGGGCATGATG  ATTTGACGTCATCCCCACCTTCCTCCGGTTTA  TCACCGGCAGTCTCGTTAGAGTGCCCAACTT  AATGATGGCAACTAACAATAGGGGTTGCGCT  CGTTGCGGGACTTAACCCAACATCTCACGAC  ACGAGCTGACGACAACCATGCACCACCTGTA  TCCCGTGTCCCGAAGGAACTTCCTATCTCTAG  GAATAGCACGAGTATGTCAAGACCTGGTAAG  GTTCTTCGCGTTGCTTCGAATTAAACCACAT  GCTCCACCGCTTGTGCGGGCCCCCGTCAATT  CCTTTGAGTTTCAACCTTGCGGTCGTACTCC  CCAGGCGGAGTGCTTATTGCGTTAGCTGCGA  TACAGAGAACTTATAGCTCCCTACATCTAGCA  CTCATCGTTTACGGCGTGGACTACCAGGGTA  TCTAATCCTGTTTGCTCCCCACGCTTTCGAG  CCTCAGTGTCAGTTACAGGCCAGAGAGCCGC  TTTCGCCACCGGTGTTCCTCCATATATCTACG  CATTTCACCGCTACACATGGAATTCCACTCTC  CTCTCCTGCACTCAAGTCTACCAGTTTCCAAT  GCATACAATGGTTGAGCCACTGCCTTTTACA  CCAGACTTAATAAACCACCTGCGCTCGCTTT  ACGCCCAATAAATCCGGACAACGCTCGGGAC  CTACGTATTACCGCGGCTGCTGGCACGTAGT  TAGCCGTCCCTTTCTGGGTAGTTACCGTCAC  TTGATGAGCTTTCCACTCTCACCAACGTTCT  TCTCTACCAACAGAGTTTTACGATCCGAAAAC  CTTCTTCACTCACGCGGCGTTGCTCGGTCAG  ACTTTCGTCCATTGCCGAAGATTCCCTACTG  CTGCCTCCCGTANGAGTTTGGGCCGTGTCTC  AGTCCCAATGTGGCCGATCACCCTCTCAGGT  CGGCTATGTATCATCGCCTTGGTGAGCCTTTA  CCTCACCAACTAGCTAATACAACGCGGGATC ATCTTTGAGTGATGCAATTGCATCTTTCAAAC  TTAAAACTTATGTTTAAAGTTGTTATGCGGTA  TTAGCATTCGTTTCCAAATGTTGTCCCCCGCT  CAAAGGCAGATTCCCCACGCGTTACTCACCC GTTCGCTGCTCTTCAAATTGGTGCAAGCACC AATCTTCATCGCTCAACTTGCATGATTAG
Identification of probiotic yeasts
We identified two yeast isolates to be S. unisporus and I. orientalis based on morphological characteristics, physiological and biochemical tests and 26S rDNAD1/D2 sequence homology with sequences AY 707865 and EU 019220 in Genbank. All the test results and sequence homology were shown in Table 4 , while all of the sequences were as follows: TGCATATTCAATAAGCGGAGGAAAAGAAACC  AACCGGGATTGCCTTAGTAACGGCGAGTGAA  GCGGCAAAAGCTCAAATTTGAAATCTAGTAC  CTTCGGTGCTCGAGTTGTAATTTGTAGAGGG  ATACTTTGGGGCCGTTCCTTGTCTATGTTCCT  TGGAACAGGACGTCATAGAGGGTGAGAATCC  CGTGTGGCGAGGAGTGCGGTTCTATGTAAAG  TGCCTTCGAAGAGTCGAGTTGTTTGGGAATG  CAGCTCTAAGTGGGTGGTAAATTCCATCTAA  AGCTAAATATTGGCGAGAGACCGATAGCGAA  CAAGTACAGTGATGGAAAGATGAAAAGAACT  TTGAAAAGAGAGTGAAAAAGTACGTGAAATT  GTTGAAAGGGAAGGGCATTTGATCAGACATG  GTGTTTTGCGCCCTCTGCTCCTTGTGGGTGG  GGGAATCTCGCAGCTCACTGGGCCAACATCA  GTTTTGGTGGTCGGATAAATCCGTAGGAATG  TGGCTTGCCTCGGCAAGTGTTATAGCCTGCG  GGAATACGGCCAGCTGGGACTGAGGACTGCC  ACTTTTGTCAAGGATGTTGGCATAATGGTTAT  ATGCCGCCCGTCTTGAAACACGGACCAA  2. I. orientalis:  GCATATCAATAAGCGGAGGAAAAGAAACCAA  CAGGGATTGCCTCAGTAGCGGCGAGTGAAGC  GGCAAGAGCTCANATTTGAAATCGTGCTTTG  CGGCACGAGTTGTAGATTGCAGGTTGGAGTC  TGTGTGGAAGGCGGTGTCCAAGTCCCTTGGA  ACAGGGCGCCCAGGAGGGTGAGAGCCCCGT  GGGATGCCGGCGGAAGCAGTGAGGCCCTTC  TGACGAGTCGAGTTGTTTGGGAATGCAGCTC  CAAGCGGGTGGTAAATTCCATCTAAGGCTAA  ATACTGGCGAGAGACCGATAGCGAACAAGTA  CTGTGAAGGAAAGATGAAAAGCACTTTGAAA  AGAGAGTGAAACAGCACGTGAAATTGTTGAA  AGGGAAGGGTATTGCGCCCGACATGGGGATT  GCGCACCGCTGCCTCTCGTGGGCGGCGCTCT  GGGCTTTCCCTGGGCCAGCATCGGTTCTTGC  TGCAGGAGAAGGGGTTCTGGAACGTGGCTC  TTCGGAGTGTTATAGCCAGGGCCAGATGCTG CGTGCGGGGACCGAGGACTGCGGCCGTGTA GGTCACGGATGCTGGCAGAACGGCGCAACA CCGCCCGTCTTGAAACACGGACCA
S. unisporus:
Discussion
Major finding of the current study is that treatment with TFCW significantly modified lipid profile and reduced CRP, ICAM-1 and VCAM-1 in atherosclerotic rabbit model. Preventive effects of TFCW in atherogenic rabbits were also demonstrated by reduction in VCAM-1 expression and formation of atheromatous plaques on aortic endothelium. In fact, accumulation of cholesterol and lipids leads to foam cell formation, which is regarded as a critical process in development of atherosclerosis [12] . Overwhelmingly strong evidence demonstrated that integrated dysregulation of serum lipidic and inflammatory components in vascular wall contributes to an early and advanced atherosclerotic development [13] . VCAM-1 is a critical mediator of adhesion and uptake of monocytes across the endothelium in the early stages of atherosclerosis development [14] , which mediates the assembly of monocytes, macrophages, T lymphocytes and platelets and their adherence to vascular wall that plays a key role in pathogenesis of atherosclerosis [15] . CRP, a phylogenetically highly conserved plasma protein, is the classical acute phase reactant in humans, and preliminary evidence for interaction of CRP with lipids implicates a possible relationship between CRP and atherosclerosis [16] . In this study, 7 potential probiotic lactobacillus species, including L. casei [17] , L. helveticus [18] , L. plantarum [19] and L. lactis [20] , which are proven probiotics, were identified in the TFCW. These LAB species may be responsible for the protective effect of TFCW against atherosclerosis in atherogenic rabbits. Indeed, LAB increase immune response [21] and reduce cholesterol [22, 23] both in animal models [24, 25] and humans [26] . LAB or LAB with active bile salt hydrolase have been suggested to lower cholesterol through interaction with host bile salt metabolism [27] .
In addition, goat milk fermented with Lactocillus fermenterum ME-3 improves antioxidant activities in human blood, thus providing antiatherogenic activity [28] . Consumption of probiotic-containing dairy food reduces cholesterol possibly through degradation of cholesterol, and probiotic lactobacilli and their metabolic by-products lower cholesterol and provide preventive and therapeutic effects against ischemic heart syndromes [6, 29] .
We also identified two probiotic yeasts in TFCW. S. unisporus is ubiquitously present in fermented milk, cheese and kefir-based milk products and may produce vitamins and interact with LAB, which may enhance LAB growth [30] . S. unisporus contains middle chain fatty acids up to C 14:0 to 18:1 and produces a high percentage of palmitoleate. Palmitoleic acid, an omega-7 monounsaturated fatty acid, is a major constituent of human adipose tissues and is considered antioxidant [31] . I.orientalis exhibits a higher tolerance for pH, bile, and heat stress for survival in gastrointestinal environment as a probiotic [32] . I. orientalis commonly exists in cheeses and other fermentation milk products and exhibits ability to scavenge 1,1 diphenyl-2-picrylhydrazyl and to inhibit lipid peroxidation, thus presenting antioxidant activity as a potential probiotic in fermented milk products [33] .
Notably, oxidized LDL in vascular wall seems to be a key factor in atherosclerosis, because oxidized LDLs might recruit monocytes and favor their transformation into foam cells through a receptor-mediated intake (scavenger pathway). Moreover, cytotoxic oxidized form of LDLs are likely responsible for endothelial cell damage and macrophage degeneration in atherosclerotic human plaque [34] . Polyunsaturated fat decreases TC and LDL-C by lowering LDL-C production rates and/or increasing LDL clearance rates [35, 36] . Consequently, omega-3polyunsaturated fatty acid (ω3-PUFA) has beneficial effects in preventing atherosclerotic diseases, and a strong positive correlation prevails between intake of saturated fatty acids and an increased incidence of CVD [37] . Therefore, inhibition of oxidation of unsaturated fatty acids is of significance for the prevention of atherosclerosis and/or CVD [38] . Furthermore, hypercholesterolemia is a major risk factor for the development of atherosclerosis [39] . Thus, we speculate that TFCW exerts its anti-atherogenic effect possibly through the identified probiotic LAB and yeasts. However, atherosclerotic effect of each individual LAB was not investigated in this study, and further studies of such effects by each kind of LAB and the possible underlying mechanisms are necessary.
Conclusions
In conclusion, current study indicates that 7 LAB and 2 yeasts identified from TFCW and TFCW have significant anti-atherosclerotic potential in atherosclerotic rabbits and may modulate lipid metabolism and protect aorta in the atherosclerotic condition, which might be related to various probiotics acting through reducing the CRP, VCAM-1 and ICAM-1 levels and protecting the aortic endothelium. 
